These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38312790)
1. Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in Japan. Mizushima I; Saeki T; Kobayashi D; Sawa N; Hayashi H; Taniguchi Y; Nakata H; Yamada K; Matsui S; Yasuno T; Masutani K; Nagasawa T; Takahashi H; Ubara Y; Yanagita M; Kawano M Kidney Int Rep; 2024 Jan; 9(1):52-63. PubMed ID: 38312790 [TBL] [Abstract][Full Text] [Related]
2. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Mizushima I; Yamamoto M; Inoue D; Nishi S; Taniguchi Y; Ubara Y; Matsui S; Yasuno T; Nakashima H; Takahashi H; Yamada K; Nomura H; Yamagishi M; Saito T; Kawano M Arthritis Res Ther; 2016 Nov; 18(1):273. PubMed ID: 27884179 [TBL] [Abstract][Full Text] [Related]
3. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Saeki T; Kawano M; Mizushima I; Yamamoto M; Wada Y; Ubara Y; Nakashima H; Ito T; Yamazaki H; Narita I; Saito T Clin Exp Nephrol; 2016 Feb; 20(1):87-93. PubMed ID: 26141243 [TBL] [Abstract][Full Text] [Related]
4. Long-term changes in renal function after treatment initiation and the importance of early diagnosis in maintaining renal function among IgG4-related tubulointerstitial nephritis patients in Japan. Arai H; Ogata S; Ozeki T; Takahashi K; Tsuboi N; Maruyama S; Inaguma D; Hasegawa M; Yuzawa Y; Hayashi H Arthritis Res Ther; 2020 Nov; 22(1):261. PubMed ID: 33153483 [TBL] [Abstract][Full Text] [Related]
5. Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study. Kawahara H; Mizushima I; Tsuge S; Shin S; Yoshinobu T; Hoshiba R; Nishioka R; Zoshima T; Hara S; Ito K; Kawano M Mod Rheumatol; 2023 Nov; 33(6):1154-1161. PubMed ID: 36300954 [TBL] [Abstract][Full Text] [Related]
6. Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort. Evans RDR; Cargill T; Goodchild G; Oliveira B; Rodriguez-Justo M; Pepper R; Connolly J; Salama A; Webster G; Barnes E; Culver EL Kidney Int Rep; 2019 Jan; 4(1):48-58. PubMed ID: 30596168 [TBL] [Abstract][Full Text] [Related]
7. IgG4-related kidney disease complicated with retroperitoneal fibrosis: A case report. He PH; Liu LC; Zhou XF; Xu JJ; Hong WH; Wang LC; Liu SJ; Zeng JH World J Clin Cases; 2023 Mar; 11(7):1656-1665. PubMed ID: 36926395 [TBL] [Abstract][Full Text] [Related]
8. Hypocomplementemia is related to elevated serum levels of IgG subclasses other than IgG4 in IgG4-related kidney disease. Fujisawa Y; Mizushima I; Yamada K; Yamamoto M; Saeki T; Matsui S; Tsuge S; Hara S; Ito K; Fujii H; Takahashi H; Nomura H; Kawa S; Kawano M Mod Rheumatol; 2021 Jan; 31(1):241-248. PubMed ID: 31903809 [TBL] [Abstract][Full Text] [Related]
10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712 [TBL] [Abstract][Full Text] [Related]
11. Clinical phenotypes and prognosis of IgG4-related diseases accompanied by deteriorated kidney function: a retrospective study. Guo L; Yang Z; Cheng Y; Wang X; Ren X; Wang M; Yan P; Shen J; Sun K; Wang H; Wu J; Chen J; Wang R Clin Rheumatol; 2024 Jan; 43(1):315-324. PubMed ID: 37642763 [TBL] [Abstract][Full Text] [Related]
12. Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients. Zeng Q; Gao J; Zhang X; Liu A; Wang Z; Wang Z; Chi X; Shi Q; Wang Y; Yang F; Liu Y; Li ZG Sci Rep; 2021 May; 11(1):10397. PubMed ID: 34001958 [TBL] [Abstract][Full Text] [Related]
13. Clinical and imaging features of IgG4-related kidney disease. Ling J; Wang H; Pan W; Li S; Guan J; Zhang X; Guo Y Abdom Radiol (NY); 2020 Jun; 45(6):1915-1921. PubMed ID: 32179977 [TBL] [Abstract][Full Text] [Related]
15. Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease. Wang R; He D; Zhao L; Liang S; Liang D; Xu F; Zhang M; Zhu X; Chen H; Xie H; Zeng C; Tang Z; Liu Z Hum Pathol; 2018 Nov; 81():220-228. PubMed ID: 30031099 [TBL] [Abstract][Full Text] [Related]
16. Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4-related kidney disease. Kawamura E; Hisano S; Nakashima H; Takeshita M; Saito T Mod Rheumatol; 2015 Jul; 25(4):571-8. PubMed ID: 25547019 [TBL] [Abstract][Full Text] [Related]
17. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings. Nakashima H; Kawano M; Saeki T; Ubara Y; Hisano S; Nagata M; Zen Y; Yanagita M; Yamaguchi Y; Nishi S; Saito T Clin Exp Nephrol; 2017 Feb; 21(1):97-103. PubMed ID: 27015831 [TBL] [Abstract][Full Text] [Related]
18. IgG4-related Kidney Disease Mimicking Malignant Ureter Tumor: Case Report and Literature Review. Lei WH; Xin J; Shao CX; Mao MF; Zhu CY; Wu CF; Jin L Medicine (Baltimore); 2016 Jan; 95(3):e2550. PubMed ID: 26817905 [TBL] [Abstract][Full Text] [Related]